These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 16706268

  • 21. State-of-the-Art Imaging and Staging of Plasma Cell Dyscrasias.
    Amini B, Yellapragada S, Shah S, Rohren E, Vikram R.
    Radiol Clin North Am; 2016 May; 54(3):581-96. PubMed ID: 27153790
    [Abstract] [Full Text] [Related]

  • 22. Diagnosing Multiple Myeloma and Related Disorders.
    Moore AR.
    Vet Clin North Am Small Anim Pract; 2023 Jan; 53(1):101-120. PubMed ID: 36270842
    [Abstract] [Full Text] [Related]

  • 23. [Dysglobulinemic neuropathies].
    Gherardi R, Zuber M, Viard JP.
    Rev Neurol (Paris); 1988 Jan; 144(6-7):391-408. PubMed ID: 2847276
    [Abstract] [Full Text] [Related]

  • 24. When a Monoclonal Gammopathy Is Not Multiple Myeloma.
    Derman B, Castillo JJ, Sarosiek S, Beksac M.
    Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-10. PubMed ID: 35394823
    [Abstract] [Full Text] [Related]

  • 25. Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders.
    Higgins L, Nasr SH, Said SM, Kapoor P, Dingli D, King RL, Rajkumar SV, Kyle RA, Kourelis T, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Ansell SM, Gonsalves WI, Thompson CA, Fervenza FC, Zand L, Hwa YL, Jevremovic D, Shi M, Leung N.
    Clin J Am Soc Nephrol; 2018 Jul 06; 13(7):1037-1046. PubMed ID: 29848505
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Paraproteinemias and Peripheral Nerve Disease.
    Leavell Y, Shin SC.
    Clin Geriatr Med; 2021 May 06; 37(2):301-312. PubMed ID: 33858612
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Skin disorders associated with monoclonal gammopathies].
    Houtman CJ, Genders RE, von dem Borne PA, Vermeer MH.
    Ned Tijdschr Geneeskd; 2014 May 06; 158():A6717. PubMed ID: 24780569
    [Abstract] [Full Text] [Related]

  • 33. Multiple myeloma and immunosecretory disorders: an update.
    Shaheen SP, Talwalkar SS, Medeiros LJ.
    Adv Anat Pathol; 2008 Jul 06; 15(4):196-210. PubMed ID: 18580096
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. MGUS and smoldering multiple myeloma: update on pathogenesis, natural history, and management.
    Rajkumar SV.
    Hematology Am Soc Hematol Educ Program; 2005 Jul 06; ():340-5. PubMed ID: 16304401
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Implications for progression to overt multiple myeloma.
    Kyle RA.
    Hematol Oncol Clin North Am; 1997 Feb 06; 11(1):71-87. PubMed ID: 9081205
    [Abstract] [Full Text] [Related]

  • 39. Screening panels for detection of monoclonal gammopathies.
    Katzmann JA, Kyle RA, Benson J, Larson DR, Snyder MR, Lust JA, Rajkumar SV, Dispenzieri A.
    Clin Chem; 2009 Aug 06; 55(8):1517-22. PubMed ID: 19520758
    [Abstract] [Full Text] [Related]

  • 40. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
    Montoto S, Rozman M, Rosiñol L, Nadal E, Giné E, Aymerich M, Ferrer A, Esteve J, Bosch F, López-Guillermo A, Bladé J, Montserrat E.
    Semin Oncol; 2003 Apr 06; 30(2):178-81. PubMed ID: 12720132
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.